Key result
Endobronchial valve therapy in COPD linked to hyperplastic granulation tissue in ~74% of cases.
Why the study?
Granulation tissue formation frequently impairs implant function after airway procedures like EBV therapy in COPD, but its underlying immunological mechanisms remain poorly understood.
What are the immunophenotypic and structural signatures of severe granulation tissue in COPD patients following airway implant procedures?
Cohort (n=158)
What are the immunophenotypic and structural signatures of severe granulation tissue in COPD patients following airway implant procedures?
Severe granulation tissue after airway implantation in COPD patients is characterized by distinct immune cell infiltration and extracellular matrix remodeling, identifying potential therapeutic targets.
May warrant closer post-EBV surveillance in COPD; leaves open immune-targeted strategies to limit granulation tissue.
Granulation tissue formation is a frequent complication following airway implant procedures such as endobronchial valve (EBV) therapy in patients with chronic obstructive pulmonary disease (COPD). This hyperplastic response can impair implant function and clinical outcomes, yet the underlying immunological mechanisms remain poorly understood. In a cohort of EBV patients (n = 147), we developed an optical scaling and scoring system to classify the severity of granulation tissue in relation to clinical outcomes. Based on this system, we prospectively collected endobronchial biopsies from EBV (n = 41) and stent patients (n = 11) for immune and structural profiling across different severity grades. Granulation tissue was analysed by histology, immunofluorescence, and flow cytometry. Using the optical scoring system, almost 75% of EBV patients developed hyperplastic granulation tissue (34.7% moderate, 38.8% severe). In many moderate to severe cases, valve dysfunction, dislocation, and the need for revision was observed. Increasing severity of granulation tissue was associated with profound extracellular matrix (ECM) disruption and increased immune cell infiltration. Immunophenotyping revealed elevated neutrophils and regulatory T cells (Tregs) with a central memory phenotype. Macrophages in patients with severe granulation tissue formation showed a shift toward a CD163+ M2-like polarisation. Structural analyses demonstrated a loss of epithelial integrity and an upregulation of ECM remodelling markers, fibronectin, and tenascin C. This study provides the first systematic immune-morphological classification of airway granulation tissue following EBV therapy. Our findings revealed distinct immune and ECM signatures associated with clinical complications identify potential mechanisms and therapeutic targets, particularly relevant for COPD patients in whom current anti-inflammatory strategies are insufficient.
No takes yet. Share an insight, caveat, or question.
Barbet et al. (2026) conducted a cohort in Chronic obstructive pulmonary disease (COPD) (n=158). Endobronchial valve (EBV) therapy was evaluated on Development of hyperplastic granulation tissue. Endobronchial valve therapy in COPD patients resulted in hyperplastic granulation tissue in 73.5% of cases (34.7% moderate, 38.8% severe), associated with immune cell infiltration and extracellular matrix disruption.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: